Research and Markets: Respiratory Tract Inflammatory Disorders Pipeline Report 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/z64f53/respiratory_tract) has announced the addition of the "Respiratory Tract Inflammatory Disorders-Pipeline Insights, 2014" subscription to their offering.

This Respiratory Tract Inflammatory Disorders Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Respiratory Tract Inflammatory Disorders.

This report provides information on the therapeutic development based on the Respiratory Tract Inflammatory Disorders dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Respiratory Tract Inflammatory Disorders Overview
  2. Respiratory Tract Inflammatory Disorders Pipeline Therapeutics
  3. Respiratory Tract Inflammatory Disorders Therapeutics under Development by Companies
  4. Respiratory Tract Inflammatory Disorders Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Respiratory Tract Inflammatory Disorders Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Respiratory Tract Inflammatory Disorders Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Respiratory Tract Inflammatory Disorders Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Respiratory Tract Inflammatory Disorders - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Respiratory Tract Inflammatory Disorders - Discontinued Products
  19. Respiratory Tract Inflammatory Disorders - Dormant Products
  20. Companies Involved in Therapeutics Development for Respiratory Tract Inflammatory Disorders
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/z64f53/respiratory_tract

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Pharmaceuticals